Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2103290Generated: October 29, 2026

1-Bromo-3-chloropropane → 1-[3-(4-Butylpiperidin-1-yl)propyl]-6-fluoro-1h-quinolin-2-one

https://huagongshe.com/reaction/2103290

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Bromo-3-chloropropaneHCID 8006—
ReactantPotassium CarbonateHCID 11430—
ReactantSodium hydrideHCID 24758—
Reactant6-Fluoro-1,2-dihydroquinolin-2-oneHCID 9834043—
Reactant4-ButylpiperidineHCID 13283867—
SolventDiethyl EtherHCID 3283—
SolventDimethylformamideHCID 6228—
SolventAcetonitrileHCID 6342—
SolventEthyl AcetateHCID 8857—
Product1-[3-(4-Butylpiperidin-1-yl)propyl]-6-fluoro-1h-quinolin-2-oneHCID 1795608029%

Reaction Steps

A 4 mL vial was charged with 6-fluoro-1H-quinolin-2-one (00.56 g, 0.34 mmol), dry DMF (2 mL) and NaH (60% in oil, 0.015 g, 0.34 mmol). The mixture was stirred at rt for 1 h under a N2 atmosphere, and thereafter 1-bromo-3-chloropropane (34 μl, 0.34 mmol) was added and the mixture was then shaken at rt for 20 h. The reaction was diluted with diethyl ether (25 mL) and washed with water (15 mL). The organic phase was washed with water (15 mL) and brine (15 mL), dried over Na2SO4, and concentrated under reduced pressure. The oily residue was diluted with CH3CN (2 mL) and KI (0.083 g, 0.50 mmol), K2CO3 (0.069 g, 0.50 mmol) and 4-butylpiperidine (0.048 g, 0.34 mmol) was added. The mixture was shaken at 50° C. for 72 h and then diluted with EtOAc (25 mL) and washed with water (15 mL). The water phase was extracted (2×25 mL) and the combined organic phase was dried over Na2SO4, and concentrated under reduced pressure. The residue was purified by cation-exchange CC followed by flash CC (SiO2; EtOAc/MeOH 4:1) to yield the title compound (0.034 g, 29%). 1H NMR (CD3OD) δ 7.90 (d, J=9.2 Hz, 1H), 7.69 (dd, J=4.0, 8.8 Hz, 1H), 7.50-7.41 (m, 2H), 6.72 (d, J=8.8 Hz, 1H), 4.41 (t, J=6.8 Hz, 2H), 3.02-2.95 (m, 2H), 2.65-2.60 (m, 2H), 2.19-2.08 (m, 2H), 1.91-1.82 (m, 4H), 1.53-1.21 (m, 9H), 0.90 (t, J=7.0 Hz); 13C NMR (CD3OD) δ 169.9, 158.4 (d, J=242 Hz), 139.8 (d, J=3 Hz), 134.4 (d, J=2 Hz), 122.5 (d, J=9 Hz), 121.6, 119.9 (d, J=24 Hz), 116.8 (d, J=8 Hz), 113.9 (d=23 Hz), 54.4, 53.0, 40.1, 34.5, 34.1, 30.1, 28.7, 23.3, 22.6, 13.2; HPLC-MS (ammonium acetate) [M+H]+=345.3.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07576100B2
Source datasetuspto-grants-2009_08
ORD IDord-7cb1d8e4f36c4dfbbbf3ec3cc4c0ad27
Source noteuspto-grants-2009_08